BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31945458)

  • 1. Sex Differences in Exercise Capacity and Quality of Life in Heart Failure With Preserved Ejection Fraction: A Secondary Analysis of the RELAX and NEAT-HFpEF Trials.
    Honigberg MC; Lau ES; Jones AD; Coles A; Redfield MM; Lewis GD; Givertz MM
    J Card Fail; 2020 Mar; 26(3):276-280. PubMed ID: 31945458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF.
    Ahmeti A; Henein MY; Ibrahimi P; Elezi S; Haliti E; Poniku A; Batalli A; Bajraktari G
    BMC Cardiovasc Disord; 2017 Oct; 17(1):268. PubMed ID: 29041912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity.
    Reddy YNV; Rikhi A; Obokata M; Shah SJ; Lewis GD; AbouEzzedine OF; Dunlay S; McNulty S; Chakraborty H; Stevenson LW; Redfield MM; Borlaug BA
    Eur J Heart Fail; 2020 Jun; 22(6):1009-1018. PubMed ID: 32150314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Beta-Blocker Use With Exercise Capacity in Participants With Heart Failure With Preserved Ejection Fraction: A Post Hoc Analysis of the RELAX Trial.
    Patel L; Segar MW; Keshvani N; Subramanian V; Pandey A; Chandra A
    Am J Cardiol; 2024 Apr; 216():48-53. PubMed ID: 38336082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Measures to Assess Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction.
    Napier R; McNulty SE; Eton DT; Redfield MM; AbouEzzeddine O; Dunlay SM
    JACC Heart Fail; 2018 Jul; 6(7):552-560. PubMed ID: 29885952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mineralocorticoid receptor antagonists on left ventricular diastolic function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials.
    Fukuta H; Goto T; Wakami K; Kamiya T; Ohte N
    Heart Vessels; 2019 Apr; 34(4):597-606. PubMed ID: 30315496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
    Fukuta H; Goto T; Wakami K; Ohte N
    Eur J Prev Cardiol; 2016 Jan; 23(1):78-85. PubMed ID: 25520380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of exercise training on cardiac function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials.
    Fukuta H; Goto T; Wakami K; Kamiya T; Ohte N
    Heart Fail Rev; 2019 Jul; 24(4):535-547. PubMed ID: 31032533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life.
    Bekfani T; Pellicori P; Morris D; Ebner N; Valentova M; Sandek A; Doehner W; Cleland JG; Lainscak M; Schulze PC; Anker SD; von Haehling S
    Clin Res Cardiol; 2019 Feb; 108(2):203-211. PubMed ID: 30051186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial.
    DeVore AD; McNulty S; Alenezi F; Ersboll M; Vader JM; Oh JK; Lin G; Redfield MM; Lewis G; Semigran MJ; Anstrom KJ; Hernandez AF; Velazquez EJ
    Eur J Heart Fail; 2017 Jul; 19(7):893-900. PubMed ID: 28194841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Impact of Noncardiac Comorbidities on Exercise Capacity and Functional Status in Chronic Heart Failure.
    Martens P; Augusto SN; Finet JE; Tang WHW
    JACC Heart Fail; 2023 Oct; 11(10):1365-1376. PubMed ID: 37389503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Weight Loss Through Lifestyle Interventions in Patients With Heart Failure With Preserved Ejection Fraction-A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    Lee VYJ; Houston L; Perkovic A; Barraclough JY; Sweeting A; Yu J; Fletcher RA; Arnott C
    Heart Lung Circ; 2024 Feb; 33(2):197-208. PubMed ID: 38320881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient reported outcome in HFpEF: Sex-specific differences in quality of life and association with outcome.
    Faxén UL; Hage C; Donal E; Daubert JC; Linde C; Lund LH
    Int J Cardiol; 2018 Sep; 267():128-132. PubMed ID: 29957252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Spironolactone on Exercise Tolerance and Arterial Function in Older Adults with Heart Failure with Preserved Ejection Fraction.
    Upadhya B; Hundley WG; Brubaker PH; Morgan TM; Stewart KP; Kitzman DW
    J Am Geriatr Soc; 2017 Nov; 65(11):2374-2382. PubMed ID: 28542926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction.
    Bobenko A; Bartels I; Münch M; Trippel T; Lindhorst R; Nolte K; Herrmann-Lingen C; Halle M; Duvinage A; Düngen HD; Gelbrich G; Tschöpe C; Hasenfuss G; Wachter R; Pieske B; Edelmann F
    ESC Heart Fail; 2018 Feb; 5(1):53-62. PubMed ID: 29210202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resting and exercise haemodynamics in relation to six-minute walk test in patients with heart failure and preserved ejection fraction.
    Wolsk E; Kaye D; Borlaug BA; Burkhoff D; Kitzman DW; Komtebedde J; Lam CSP; Ponikowski P; Shah SJ; Gustafsson F
    Eur J Heart Fail; 2018 Apr; 20(4):715-722. PubMed ID: 28949052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pragmatic Weight Management Program for Patients With Obesity and Heart Failure With Preserved Ejection Fraction.
    El Hajj EC; El Hajj MC; Sykes B; Lamicq M; Zile MR; Malcolm R; O'Neil PM; Litwin SE
    J Am Heart Assoc; 2021 Nov; 10(21):e022930. PubMed ID: 34713711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular endothelial dysfunction in skin is associated with higher risk of heart failure with preserved ejection fraction in women with type 2 diabetes: the Hoorn Diabetes Care System Cohort.
    Canto ED; van Deursen L; Hoek AG; Elders PJM; den Ruijter HM; van der Velden J; van Empel V; Serné EH; Eringa EC; Beulens JWJ
    Cardiovasc Diabetol; 2023 Sep; 22(1):234. PubMed ID: 37658327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.